04 - Neurosurgical / 04.05 - NEUROSTIMULATION THERAPIES FOR PAIN MANAGEMENT / 04.05.03 - Leads

04.05.03.01 - Permanent Lead · 8 electrodes

6 devices · 4 sponsors

March 2027 window closes in 92 days

Median benefit

$3817.00

Range

$3817–3817

Comparator candidates

Code	Device · sponsor	Benefit	Tier 1 comparator?
BS109	Precision SCS Eight Contact Leads BOSTON SCIENTIFIC PTY LTD	$3817.00	eligible
BS331	Avista MRI 8 Contact Lead BOSTON SCIENTIFIC PTY LTD	$3817.00	eligible
MI136	Vectris Surescan MRI Neurostimulation Leads MEDTRONIC AUSTRALASIA PTY LTD	$3817.00	eligible
SJ161	Octrode Leads ABBOTT MEDICAL AUSTRALIA PTY LTD.	$3817.00	eligible
SJ185	Lamitrode S Series ABBOTT MEDICAL AUSTRALIA PTY LTD.	$3817.00	eligible
WW006	Nevro Spinal Cord Stimulation System (SCSS) - Lead Kit Nevro Medical Pty Ltd	$3817.00	eligible

6 device(s).

Tier pre-screener

Indicative only — pathway choice is the sponsor's responsibility.

TGA class of your device Well-established technology? Listing in this existing grouping? Interchangeable with a comparator here?

4-year benefit estimate

For the HPP utilisation section — arithmetic on your inputs.

Benefit $ Units/yr (low) Units/yr (high)

Year	Low	High
4-year total

Data: current Prescribed List · Calculations are based on published government data and figures you enter — a lookup and arithmetic tool, not regulatory or billing advice · Not an official government service.